Results 211 to 220 of about 103,481 (331)

Dopamine Agonists as a Novel "Cure" for Autoimmune Diabetes. [PDF]

JCEM Case Rep
Sahota S, Cooper L, Sirkova A, Stojanovic N.   +3 more
europepmc   +1 more source

Erratum to “estimation of the interstitial free concentration of the putative dopamine D3 receptor selective agonist 7-OH-DPAT in the dorsal striatum of freely moving rats” [Neurosci. Lett. 193 (1995) 65–67]

, 1995
Raul R. Gainetdinov, Tatyana D. Sotnikova, Tatyana V. Grekhova, K.S. Rayevsky   +3 more
openalex   +1 more source

Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial

Movement Disorders, EarlyView.
Abstract Background Neuroinflammation contributes to Parkinson's disease (PD) progression and motor dysfunction. Allogeneic human mesenchymal stem cells (allo‐hMSCs) may reduce neuroinflammation and improve motor symptoms. Objectives To evaluate the efficacy of repeated intravenous doses of 10 × 106/kg allo‐hMSCs in improving motor symptoms in patients
Mya C. Schiess, Jessika Suescun, Juan D. Martinez‐Lemus, Charles Green, Tia S. Thomas, Mohammad Shahnawaz, Emily Tharp, Nikunj B. Satani, Jerome G. Saltarrelli, Christopher Adams, Marie‐Francoise Doursout, Vanessa Thyne, Rula Abuamouneh, Elsa M. Rodarte, Sean I. Savitz, Timothy M. Ellmore   +15 more
wiley   +1 more source

Comparative safety signals of dopamine agonists: psychiatric and cardiovascular risks derived from FDA adverse event reporting system (FAERS) data. [PDF]

BMC Pharmacol Toxicol
Mu L, Xu J, Ye X, Jiang Y, Yi Z.
europepmc   +1 more source

Long‐duration effect and the postsynaptic compartment: Study using a dopamine agonist with a short half‐life [PDF]

, 2001
Fabrizio Stocchi, Laura Vacca, Alfredo Berardelli, Francesca De Pandis, Stefano Ruggieri   +4 more
openalex   +1 more source

Effects of a Four‐Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical Trial

Movement Disorders, EarlyView.
Abstract Background Gut dysbiosis and gut‐brain‐axis involvement in people with Parkinson's disease (PwP) support the use of gut‐microbiota‐modulating interventions. Probiotics may help manage constipation in PwP; however, mechanisms underpinning additional beneficial properties are unknown.
Valentina Leta, Pavlos Zinzalias, Lucia Batzu, Gargi Mandal, Juliet Staunton, Frida Jernstedt, Kristina Rosqvist, Jonathan Timpka, Trinette van Vliet, Dhaval Trivedi, Aleksandra Podlewska, Miriam Parry, Daniel J. van Wamelen, Alexandra Rizos, Carolina Sportelli, Ana Laura Bonder, Guy Chung‐Faye, Cristian Falup‐Pecurariu, Simon Gaisford, Edoardo Moretto, Gwenaelle Le Gall, David Vauzour, Ana Rodriguez‐Mateos, Anna Sauerbier, Carmen Rodriguez Blazquez, Jonas Ghyselinck, Benoît Marsaux, Carmine Maria Pariante, Alessandra Borsini, Per Odin, Kallol Ray Chaudhuri   +30 more
wiley   +1 more source

Cortico-striatal circuit mechanisms drive the effects of D1 dopamine agonists on memory capacity in mice through cAMP/PKA signalling. [PDF]

Nat Commun
De Risi M, Cavezza D, Torromino G, Capalbo A, Cundin XB, Di Martino R, Alvino FG, Iemolo A, Speranza L, Perrone-Capano C, Crispino M, Cirillo C, Luini A, Sacco F, Grumati P, De Leonibus E.   +15 more
europepmc   +1 more source

Reply: “Improving the Study of Impulse Control Disorders in CSAI‐Treated Parkinson's Disease: Methodological and Interdisciplinary Directions”

Movement Disorders Clinical Practice, EarlyView.
Clément Desjardins, Paulo André Dias Bastos, Margherita Fabbri   +2 more
wiley   +1 more source

Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study. [PDF]

J Endocrinol Invest, 2021
Beccuti G, Guaraldi F, Natta G, Cambria V, Prencipe N, Cicolin A, Montanaro E, Lopiano L, Ghigo E, Zibetti M, Grottoli S.   +10 more
europepmc   +1 more source

Differential Effects of Direct and Indirect Dopamine Agonists on Prepulse Inhibition: A Study in D1 and D2 Receptor Knock-Out Mice [PDF]

, 2002
Rebecca J. Ralph-Williams, Virginia Lehmann-Masten, Veronica Otero-Corchón, Malcolm J. Low, Mark A. Geyer   +4 more
openalex   +1 more source